Advertisement
Screener

UNIGENE LABORATORIES INC Facility Costs

UNIGENE LABORATORIES INC Facility Costs

UNIGENE LABORATORIES INC reported Facility Costs of $529.25 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:FacilityCosts · last filed 2013-05-14

  • UNIGENE LABORATORIES INC facility costs for the quarter ending 2013-03-31 was $529.25K, a 38.40% decline year-over-year.
  • UNIGENE LABORATORIES INC facility costs for the quarter ending 2012-12-31 was $897.88K, a 4.02% increase year-over-year.
  • UNIGENE LABORATORIES INC facility costs for the quarter ending 2012-09-30 was $712.53K, a 19.36% decline year-over-year.
  • UNIGENE LABORATORIES INC facility costs for the quarter ending 2012-06-30 was $678.29K, a 20.12% decline year-over-year.
  • UNIGENE LABORATORIES INC facility costs for fiscal 2012 was $3.15M, a 5.92% decline from fiscal 2011.
  • UNIGENE LABORATORIES INC facility costs for fiscal 2011 was $3.35M, a 7.73% increase from fiscal 2010.
  • UNIGENE LABORATORIES INC facility costs for fiscal 2010 was $3.11M, a 81.46% increase from fiscal 2009.
  • UNIGENE LABORATORIES INC facility costs for fiscal 2009 was $1.71M.
Period endFacility Costs 3 monthFacility Costs 6 monthFacility Costs 9 monthFacility Costs 12 month
2013-03-31$529.25K
10-Q · filed 2013-05-14
$1.43M
derived: sum of 2 quarters · filed 2013-05-14
$2.14M
derived: sum of 3 quarters · filed 2013-05-14
$2.82M
derived: sum of 4 quarters · filed 2013-05-14
2012-12-31$897.88K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$1.61M
derived: sum of 2 quarters · filed 2013-03-15
$2.29M
derived: sum of 3 quarters · filed 2013-03-15
$3.15M
10-K · filed 2013-03-15
2012-09-30$712.53K
10-Q · filed 2013-01-31
$1.39M
derived: sum of 2 quarters · filed 2013-01-31
$2.25M
10-Q · filed 2013-01-31
$3.11M
derived: sum of 4 quarters · filed 2013-05-14
2012-06-30$678.29K
10-Q/A · filed 2013-01-31
$1.54M
10-Q/A · filed 2013-01-31
$2.40M
derived: sum of 3 quarters · filed 2013-05-14
$3.28M
derived: sum of 4 quarters · filed 2013-05-14
2012-03-31$859.11K
10-Q · filed 2013-05-14
$1.72M
derived: sum of 2 quarters · filed 2013-05-14
$2.61M
derived: sum of 3 quarters · filed 2013-05-14
$3.46M
derived: sum of 4 quarters · filed 2013-05-14
2011-12-31$863.18K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$1.75M
derived: sum of 2 quarters · filed 2013-03-15
$2.60M
derived: sum of 3 quarters · filed 2013-03-15
$3.35M
10-K · filed 2013-03-15
2011-09-30$883.62K
10-Q · filed 2013-01-31
$1.73M
derived: sum of 2 quarters · filed 2013-01-31
$2.48M
10-Q · filed 2013-01-31
$3.25M
derived: sum of 4 quarters · filed 2013-03-15
2011-06-30$849.12K
10-Q/A · filed 2013-01-31
$1.60M
10-Q/A · filed 2013-01-31
$2.37M
derived: sum of 3 quarters · filed 2013-03-15
$3.14M
derived: sum of 4 quarters · filed 2013-03-15
2011-03-31$750.06K
10-Q/A · filed 2013-01-31
$1.52M
derived: sum of 2 quarters · filed 2013-03-15
$2.29M
derived: sum of 3 quarters · filed 2013-03-15
$3.06M
derived: sum of 4 quarters · filed 2013-03-15
2010-12-31$767.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$1.54M
derived: sum of 2 quarters · filed 2013-03-15
$2.31M
derived: sum of 3 quarters · filed 2013-03-15
$3.11M
10-K · filed 2013-03-15
2010-09-30$773.99K
10-Q · filed 2011-11-09
$1.54M
derived: sum of 2 quarters · filed 2011-11-09
$2.34M
10-Q · filed 2011-11-09
2010-06-30$768.43K
10-Q · filed 2011-08-09
$1.56M
10-Q · filed 2011-08-09
2009-12-31$1.71M
10-K/A · filed 2013-01-31